ALK-Abelló A/S ( AKBLF) - Key Metrics
AKBLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $8.06 | $1.52 | $1.30 | $1.09 |
| 2026Q1 | $8 | $1.97 | $3.44 | $3.23 |
| 2025Q4 | $7.80 | $1.20 | $3.25 | $2.82 |
| 2025Q3 | $6.82 | $1.40 | $1.72 | $1.34 |
| 2025Q2 | $6.97 | $1.20 | $1.46 | $0.98 |
AKBLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 44.34 |
| 2026Q1 | 81.24% | 25.99 |
| 2025Q4 | 0% | 47.43 |
| 2025Q3 | 0% | 32.89 |
| 2025Q2 | 0% | 36.46 |
AKBLF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.41% | 0% |
| 2026Q1 | 1.59% | 0.79% |
| 2025Q4 | 1.23% | 0% |
| 2025Q3 | 0.73% | 0% |
| 2025Q2 | 0.56% | 0% |
AKBLF
Price: $32.47
52 week price:
Dividend Yield: 0.64%
5-year range yield:
Forward Dividend Yield: 0.78%
Payout Ratio Range:
Dividend Per Share: 0.25 USD
Earnings Per Share: 0.96 USD
P/E Ratio: 32.66
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 1